<DOC>
	<DOCNO>NCT00944203</DOCNO>
	<brief_summary>This open label , prospective , test superiority efficacy trial Ipomea pes-caprae ointment add-on therapy patient jellyfish dermatitis . Each patient receive standard medical treatment depend severity disease . The doctor divide dermatitis area patient two part . Ipomea pes-caprae ointment apply add-on therapy `` test area '' , ointment apply `` control area '' . Patients ask come follow 6 time 28-days study period . Primary objective compare heal time dermatitis area .</brief_summary>
	<brief_title>Efficacy Ipomea Pes-caprae Ointment add-on Therapy Patient With Jellyfish Dermatitis</brief_title>
	<detailed_description>The `` Test area '' `` Control area '' allocate participant . We use Internal Control fashion . The healing time area collect outcome measure .</detailed_description>
	<mesh_term>Dermatitis</mesh_term>
	<criteria>clinical diagnosis jellyfish dermatitis total lesion area 4 square centimeter expose jellyfish 7 day severe systemic reaction jellyfish allergy Ipomea pescaprae component ointment</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2016</verification_date>
	<keyword>jellyfish</keyword>
	<keyword>jellyfish venom</keyword>
	<keyword>jellyfish dermatitis</keyword>
	<keyword>jellyfish sting</keyword>
	<keyword>Ipomea pes-caprae</keyword>
</DOC>